Shao et al. found that 11β-HSD1 inhibition can exert a potential benefit in terms of reducing obesity and lowering IR by modulating the insulin signaling pathway and adipocytokine production [19]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.